ArticleOncoTargets and therapy2021

Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide.

Huihan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.